PL2473172T3 - Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca - Google Patents

Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca

Info

Publication number
PL2473172T3
PL2473172T3 PL10814383T PL10814383T PL2473172T3 PL 2473172 T3 PL2473172 T3 PL 2473172T3 PL 10814383 T PL10814383 T PL 10814383T PL 10814383 T PL10814383 T PL 10814383T PL 2473172 T3 PL2473172 T3 PL 2473172T3
Authority
PL
Poland
Prior art keywords
methods
heart failure
treating heart
bisphosphonate compositions
bisphosphonate
Prior art date
Application number
PL10814383T
Other languages
English (en)
Inventor
Kenneth W Lyles
Cathleen S Colon-Emeric
Christopher M O'connor
Richard S Stack
Colleen Stack-D'niaye
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of PL2473172T3 publication Critical patent/PL2473172T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL10814383T 2009-09-01 2010-09-01 Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca PL2473172T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23879709P 2009-09-01 2009-09-01
EP10814383.5A EP2473172B1 (en) 2009-09-01 2010-09-01 Bisphosphonate compositions and methods for treating heart failure
PCT/US2010/047417 WO2011028737A2 (en) 2009-09-01 2010-09-01 Bisphosphonate compositions and methods for treating heart failure

Publications (1)

Publication Number Publication Date
PL2473172T3 true PL2473172T3 (pl) 2015-08-31

Family

ID=43649931

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10814383T PL2473172T3 (pl) 2009-09-01 2010-09-01 Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca

Country Status (12)

Country Link
US (2) US9867838B2 (pl)
EP (1) EP2473172B1 (pl)
CN (2) CN105920023A (pl)
DK (1) DK2473172T3 (pl)
ES (1) ES2537216T3 (pl)
HR (1) HRP20150496T1 (pl)
HU (1) HUE025737T2 (pl)
PL (1) PL2473172T3 (pl)
PT (1) PT2473172E (pl)
SI (1) SI2473172T1 (pl)
SM (1) SMT201500124B (pl)
WO (1) WO2011028737A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
WO2013074587A1 (en) * 2011-11-16 2013-05-23 Duke University Bishophonate compositions and methods for treating and/or reducing cardiac dysfunction
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US20230149430A1 (en) * 2020-04-06 2023-05-18 Duke University Compositions and methods for the treatment of infection-induced cardiomyopathy

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE3428524A1 (de) 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4639338A (en) 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
DE3770982D1 (de) 1986-04-24 1991-08-01 Fujisawa Pharmaceutical Co Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3776880D1 (de) 1986-11-21 1992-04-02 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
US5057505A (en) 1986-11-21 1991-10-15 Ciba-Geigy Corporation Substituted aminomethanediphosphonic acids and use in medicaments
GB8808138D0 (en) 1988-04-07 1988-05-11 Leo Pharm Prod Ltd Chemical compounds
DE69108733T2 (de) * 1990-08-21 1995-09-14 Upjohn Co Bisphosphonsäurederivate als antiarthritische mittel.
US5157027A (en) 1991-05-13 1992-10-20 E. R. Squibb & Sons, Inc. Bisphosphonate squalene synthetase inhibitors and method
KR100244603B1 (ko) 1991-05-28 2000-03-02 데이비드 엠 모이어 칼슘,미량무기물,비타민 디 또는 디포스포네이트를 포함하는 골 강화용 식품 보충제
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
EP0600834A1 (en) 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
US5403829A (en) 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FI92465C (fi) 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5646134A (en) 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US6117856A (en) 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
DE19738005A1 (de) 1997-08-30 1999-03-04 Bayer Ag Verwendung von substituierten 1,1-Bisphosphonaten
AU760703B2 (en) 1998-01-29 2003-05-22 Merck & Co., Inc. Methods of identifying modulators of kinases responsive to stress
US6984400B2 (en) 1998-07-14 2006-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating restenosis using bisphosphonate nanoparticles
EP1267888A4 (en) 2000-01-04 2005-12-28 Univ California USE OF LOW DOSE BISPHOSPHONATES TO INHIBIT CARDIAC AND ARTERIAL CALCIFICATION
AU2001239953A1 (en) * 2000-03-01 2001-09-12 University Of South Florida Methods of modulating cell-adhesion mediated drug resistance
GB0012209D0 (en) 2000-05-19 2000-07-12 Novartis Ag Organic compounds
CA2410201C (en) 2000-06-20 2010-10-26 Novartis Ag Zoledronic acid or salts thereof for use in the treatment of conditions of abnormally increased bone turnover
EP1418897A2 (en) * 2001-05-02 2004-05-19 Novartis AG Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
US20030064965A1 (en) 2001-10-02 2003-04-03 Jacob Richter Method of delivering drugs to a tissue using drug-coated medical devices
CA2480814A1 (en) 2002-04-05 2003-10-23 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
EP1506208A4 (en) 2002-05-11 2006-05-24 Ilex Products Inc 1,1- AND 1,2-BISPHOSPHONATES AS MODULATORS OF APOLIPOPROTEIN E
US20050026871A1 (en) 2002-07-17 2005-02-03 Moshe Flashner-Barak Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
CA2497353C (en) 2002-09-16 2012-08-28 Novartis Ag Method for preventing or reducing secondary fractures after hip fracture
JP2006504749A (ja) 2002-10-15 2006-02-09 ノバルティス アクチエンゲゼルシャフト アテローム性動脈硬化症の処置のためのビスホスホネートおよびそれらを含むデバイス
BR0317885A (pt) * 2002-12-30 2005-12-06 Celgene Corp Composto, isÈmeros s e r enantiomericamente puros do mesmo, composição farmacêutica e métodos de inibir pde4 e mmp, de modular a produção de tnf-alfa, de tratar ou prevenir mds, de tratar doença mieloproliferativa, angiogênese indesejada, câncer, uma doença, inflamação dos pulmões, depressão, distúrbio pulmonar obstrutivo crÈnico, doença inflamatória do intestino, dermatite atópica, psorìase, doença de crohn, artrite reumatóide, asma, eslcerose múltipla e doença cardìaca em um mamìfero e de tratar, prevenir ou controlar a sìndrome de dor regional complexa
US20060051407A1 (en) 2003-06-27 2006-03-09 Yoram Richter Method of treating ischemia-reperfusion injury
US10517883B2 (en) 2003-06-27 2019-12-31 Zuli Holdings Ltd. Method of treating acute myocardial infarction
WO2005002545A1 (en) 2003-06-27 2005-01-13 Biorest Ltd. Method of treating acute coronary syndromes
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
WO2005027921A1 (en) 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate
GB0327742D0 (en) * 2003-11-28 2003-12-31 Isis Innovation Novel uses of known drugs
EP1796683A1 (en) * 2004-07-15 2007-06-20 Nanobac Life Sciences Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
US20060069068A1 (en) 2004-07-15 2006-03-30 Nanobac Pharmaceuticals, Inc. Methods and compositions for the treatment of diseases characterized by pathological calcification
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
BRPI0710503A2 (pt) * 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
EP1925621A1 (en) * 2006-11-27 2008-05-28 Novartis AG Crystalline forms of zoledronic acid
US20080146489A1 (en) 2006-12-15 2008-06-19 Pacetti Stephen D Regional delivery of therapeutic agents for the treatment of vascular diseases
EP2136814A4 (en) 2007-03-21 2012-05-30 Univ Duke MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE
EP2222636B1 (en) * 2007-12-21 2013-04-10 Ligand Pharmaceuticals Inc. Selective androgen receptor modulators (sarms) and uses thereof
CN101259133A (zh) * 2008-03-28 2008-09-10 王洪 唑来磷酸用于制备预防及治疗骨质疏松症的药物
US20110112053A1 (en) 2008-04-16 2011-05-12 University Of Utah Research Foundation Pharmacological targeting of vascular malformations

Also Published As

Publication number Publication date
WO2011028737A8 (en) 2012-05-18
SMT201500124B (it) 2015-07-09
EP2473172A2 (en) 2012-07-11
US20120208786A1 (en) 2012-08-16
EP2473172A4 (en) 2013-01-16
HUE025737T2 (en) 2016-05-30
EP2473172B1 (en) 2015-04-08
HRP20150496T1 (hr) 2015-08-14
ES2537216T3 (es) 2015-06-03
WO2011028737A3 (en) 2011-07-14
CN105920023A (zh) 2016-09-07
SI2473172T1 (sl) 2015-07-31
US20180125869A1 (en) 2018-05-10
US9867838B2 (en) 2018-01-16
PT2473172E (pt) 2015-06-25
DK2473172T3 (en) 2015-06-15
WO2011028737A2 (en) 2011-03-10
CN102639137A (zh) 2012-08-15

Similar Documents

Publication Publication Date Title
EP2440209A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
IL215975A (en) Heart failure device
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
IL239918A0 (en) Preparations for the treatment of colitis
IL212348A0 (en) Treatment method
ZA201106165B (en) Compositions and methods for preventing cardiac arrhythmia
EP2575669A4 (en) SUPPORTED DENTAL IMPLANT TREATMENT
IL215932A0 (en) Compositions and methods for treating burns
GB0802116D0 (en) Treatment
PL2391391T3 (pl) Sposób sterylizacji
IL210097A0 (en) Compositions and methods for treating unfluenza
EP2575855A4 (en) METHOD FOR TREATING OR PREVENTING VASCULAR GRAFT BREAKAGE
EP2459206A4 (en) METHODS OF TREATMENT USING THYMUS-BASED COMPOSITIONS
EP2486890A4 (en) SUPPORT FOR AN IMPLANT
IL217492A0 (en) Treatment method
IL219565A0 (en) Method for treating heart failure with stresscopin-like peptides
SG10201408508YA (en) Combination composition useful for treating cardiovascular diseases
SI2473172T1 (sl) Bisfosfonat sestavki in postopki za zdravljenje srčne okvare
EP2485853A4 (en) TREATMENT OF FLOORS
GB0811992D0 (en) Treatment
GB0900599D0 (en) Treatment
EP2512504A4 (en) COMPOSITION AND THERAPEUTIC METHOD
GB0913968D0 (en) Treatment
GB0806047D0 (en) Treatment of heart failure
PL2263454T3 (pl) Kompozycja uzdatniająca